Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBabcock Regulatory News (BAB)

Share Price Information for Babcock (BAB)

Share Price is delayed by 15 minutes
Get Live Data
1,046.00    13.50 (1.31%)
Bid:
1,038.00
Ask:
1,039.00
Spread: 1.00 (0.096%)
Market Cap: £5.12b
BAB Live PriceLast checked at - London Stock Exchange

Intraday Babcock Share Chart

Director appointment

14 Feb 2024 09:00

RNS Number : 1099D
Babcock International Group PLC
14 February 2024
 

Director appointment

 

14 February 2024

 

Babcock International Group PLC ("Babcock" or "the Group") is pleased to announce the appointment of Dr Claudia Natanson MBE as Non-Executive Director. Claudia will join the Board on 1 March 2024.

 

Claudia works internationally as an information and cybersecurity professional and consultant. She brings over twenty years of experience in this field, alongside areas such as digital transformation and enterprise risk management in globally diverse industries in both the public and private sectors. She is currently the Chair of the Board of Trustees of the UK Cyber Security Council and a Board member of the UK National Cyber Advisory Board. 

 

Claudia started her career with a degree in Chemistry and Nuclear Chemistry, went on to complete a Masters in Computer Science, a PhD in Computers and Education before holding senior roles in cyber and security in companies such as Aramark Corporation in the USA, the UK Government's Department for Work and Pensions, Smiths Group plc and Diageo global. 

 

 

Ends

 

 

For further information:

 

 

Andrew Gollan, Director of Investor Relations

+44 (0)7936 039004

Kate Hill, Group Director of Communications

+44 (0)7899 792991

 

 

Teneo

 

Olivia Peters / Harry Cameron

+44 (0)20 7353 4200

 

 

Notes

 

There are no further matters to be disclosed under LR9.6.13R of the Listing Rules of the UK Listing Authority.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEAPALFDLLEEA
Date   Source Headline
4th Aug 20257:00 amRNSTransaction in Own Shares
1st Aug 202511:36 amRNSTotal Voting Rights
1st Aug 20257:00 amRNSTransaction in Own Shares
31st Jul 202512:02 pmRNSDirector/PDMR Shareholding
30th Jul 20257:00 amRNSTransaction in Own Shares
29th Jul 20255:00 pmRNSNotice of AGM
29th Jul 20257:00 amRNSTransaction in Own Shares
28th Jul 20257:00 amRNSTransaction in Own Shares
25th Jul 20257:00 amRNSTransaction in Own Shares
23rd Jul 20256:27 pmRNSLaunch of Share Buyback Programme
7th Jul 20253:36 pmRNSDirector/PDMR Shareholding
3rd Jul 20253:57 pmRNSDirector/PDMR Shareholding
1st Jul 20255:41 pmRNSFinal Results
25th Jun 20257:00 amRNSPreliminary results for the year ended 31.03.2025
17th Jun 20253:30 pmRNSHolding(s) in Company
10th Jun 20251:11 pmRNSHolding(s) in Company
9th Jun 20254:23 pmRNSDirector Announcement
5th Jun 20259:00 amRNSDirectorate Change
20th May 202512:48 pmRNSBabcock host Cavendish Nuclear teach-in event
23rd Apr 20257:00 amRNSFY25 Post-close Trading Update
26th Mar 20257:30 amRNSBabcock awarded five-year British Army contract
19th Mar 20256:00 pmRNSHargreaves Lansdown
7th Feb 20253:16 pmRNSHolding(s) in Company
6th Feb 20257:00 amRNSQ3 trading update and upgrade of FY25 expectations
30th Jan 20254:05 pmRNSHolding(s) in Company
21st Jan 20253:55 pmRNSDirector/PDMR Shareholding
27th Nov 202411:37 amRNSDirector/PDMR Shareholding
18th Nov 20243:06 pmRNSDirector/PDMR Shareholding
18th Nov 20242:34 pmRNSChange of Record Date for Interim Dividend
14th Nov 20244:33 pmRNSDirector/PDMR Shareholding
14th Nov 202411:50 amRNSDirector announcement
13th Nov 20247:00 amRNSResults for the six months ended 30 September 2024
4th Oct 20242:52 pmRNSDirector/PDMR Shareholding
3rd Oct 20244:13 pmRNSDirector/PDMR Shareholding
1st Oct 20243:04 pmRNSHolding(s) in Company
30th Sep 20243:41 pmRNSDirector/PDMR Shareholding
26th Sep 20242:49 pmRNSDirector/PDMR Shareholding
19th Sep 20243:35 pmRNSResult of AGM
19th Sep 20247:00 amRNSAGM trading update
6th Sep 202411:48 amRNSDirector/PDMR Shareholding
29th Aug 20244:33 pmRNSDirector/PDMR Shareholding - Replacement
29th Aug 20241:26 pmRNSDirector/PDMR Shareholding
15th Aug 20241:01 pmRNSNotice of AGM
7th Aug 20249:44 amRNSDirector/PDMR Shareholding
6th Aug 202411:28 amRNSDirector/PDMR Shareholding
5th Aug 20244:26 pmRNSDirector/PDMR Shareholding
2nd Aug 202412:02 pmRNSDirector/PDMR Shareholding
1st Aug 20243:48 pmRNSDirector/PDMR Shareholding
30th Jul 20249:53 amRNSAnnual Financial Report
26th Jul 20247:00 amRNSFull year results for the year ended 31 March 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.